Song Zhao, MD - Medical Oncology-Swedish Cancer Institute First Hill

"Dr. Michaela Tsai is a board certified medical oncologist and hematologist who has been caring for patients with cancer and blood disorders for nearly 20 years. At Duke University, Dr. Tsai studied chemistry and religion. During her medical training at Harvard, she discovered that the field of oncology allowed her to stay actively engaged in both areas. The health and well-being of her patients is her primary concern. She believes in the essential balance between the intellectual and the emotional, the scientific and the spiritual, and incorporates these elements into her daily practice and the care of her patients."

"Dr. Alassas is a 2021 Seattle Met Top Doctor Award winner. Dr. Alassas is a specialized surgical oncologist with extensive experience in complex abdominal and oncologic surgery. He is dedicated to delivering the best quality care and highest level of safety to his patients. His treatment philosophy is patient centered and tailored to each individual. Dr. Alassas' clinical approach is based on collaborating with the patient and their treatment team to formulate a treatment plan that delivers the best potential outcome. This includes paying attention to details pertaining to both the patient and the disease process, applying best practice measures and excellent surgical skills, and utilizing innovative and cutting edge treatment methods. Clinical interests include surgical oncology, peritoneal surface malignancies, soft tissue tumors, retroperitoneal tumors, melanoma metastasectomy, clinical research, cancer prevention, and personalized cancer treatment."

"Dr. Patel is a 2019 Seattle Met Top Doctor Award winner. He is passionate about caring for patients with all forms of blood cancers and has a particular interest in lymphomas. Dr. Patel recognizes each patient's illness experience is unique and is focused on providing care that is both evidence-based and personalized to the individual patient. He values the importance of communication in the physician-patient experience and emphasizes shared decision making to help patients navigate their illness. He is excited to help develop novel therapies for blood cancer patients through clinical trials at Swedish."